Blog

The pharma industry requires precise regulatory data, solid documentation, and relevant market intelligence. With the rising levels of competition and evolving regulatory requirements, pharma firms require more than just traditional regulatory data to capitalize on opportunities and develop their business plans. Pharmaceutical intelligence from dossier and drug master file (DMF) can assist in understanding regulatory […]

Nothing like the knowledge pharmaceutical firms possess today has ever been known before. Information can be sourced from corporate records, governmental agencies, clinical trials, scientific journals, production processes, market surveys, and suppliers. The challenge is no longer simply finding information. The bigger challenge is understanding how different pieces of information connect and turning them into […]

The pharmaceutical industry is constantly changing. New treatments are emerging, new competitors are gaining market access in new territories, new regulations are in flux, and new customers are being better educated. At the same time, pharmaceutical companies have access to more information than ever before. But more data is not necessarily better data. The true […]

Pharmaceutical supply chain was considered a function for years. The goal was simple: locate the most reliable suppliers, acquire the best materials, monitor expenses, produce their products, and get them to their consumers. This is changing. In today’s world, a disruption in one area can impact manufacturing in another. Lack of an API may affect […]

Pharma databases are often associated by people with huge libraries of information containing drug names, company names, and product information. This may be only one aspect of what the database holds. Pharmaceutical databases with proper structure could include information regarding products, manufacturers, suppliers, companies, regulations, patents, drug development, competition, and markets. However, all the value […]

Pharmaceutical Industry produces a terrific amount of data. There’s the market reports, sales data, clinical trials, regulatory updates, competitor launches, patent developments, pricing information, manufacturer databases, supply-chain changes, and industry news. The difficulty isn’t in the information itself. The problem is getting a good grasp on what’s important. A pharmaceutical company can spend weeks gathering […]

Pharmaceutical companies have access to more information on the market than ever before. They can monitor the market size, historical sales, epidemiology, competitors, product launches, regulatory changes, pricing and other trends in the market. However, despite all this information, the task of pharmaceutical forecasting is still a difficult one. A market can look like it’s […]

There’s a number worth pausing on. India’s pharmaceutical exports reached $30.47 billion in FY2024–25, a 9.4% rise over the previous year, with medicines reaching over 200 markets worldwide. For context, that figure represents a nearly 16-fold increase from just $1.9 billion in 2000–01. IBEFPress Information Bureau That’s not incremental growth. That’s a structural transformation — […]

Internet connection and payment information is required for the ordering of these items.The business of generic drugs may appear to be straightforward on the surface.When a drug becomes generic it loses its brand name. Internationally, generic manufacturers come on board. The pricing becomes more competitive! Patients come into contact with cheaper drugs. Simple, right? Not […]

In the beginning, selecting the right supplier in the pharmaceutical industry has always been a challenging process. You do not only need someone that can deliver on time or provide a competitive quote, you’re seeking a manufacturer whose processes, certifications and compliance record will withstand regulatory review. A single bad choice in a vendor can […]